Newbridge Financial Services Group’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18K | Buy |
1,050
+750
| +250% | +$12.8K | ﹤0.01% | 748 |
|
|
2025
Q1 | $19.1K | Hold |
300
| – | – | ﹤0.01% | 554 |
|
|
2024
Q4 | $36.5K | Buy |
+300
| New | +$36.5K | 0.01% | 478 |
|
|
2024
Q3 | – | Sell |
-300
| Closed | -$47.4K | – | 1058 |
|
|
2024
Q2 | $47.4K | Hold |
300
| – | – | 0.02% | 389 |
|
|
2024
Q1 | $38.8K | Hold |
300
| – | – | 0.02% | 447 |
|
|
2023
Q4 | $28.9K | Sell |
300
-43
| -13% | -$4.15K | 0.01% | 515 |
|
|
2023
Q3 | $41.6K | Sell |
343
-300
| -47% | -$36.4K | 0.02% | 456 |
|
|
2023
Q2 | $73.6K | Hold |
643
| – | – | 0.04% | 368 |
|
|
2023
Q1 | $88.6K | Hold |
643
| – | – | 0.05% | 335 |
|
|
2022
Q4 | $83.3K | Hold |
643
| – | – | 0.05% | 334 |
|
|
2022
Q3 | $71K | Sell |
643
-168
| -21% | -$18.6K | 0.04% | 368 |
|
|
2022
Q2 | $61K | Sell |
811
-382
| -32% | -$28.7K | 0.04% | 362 |
|
|
2022
Q1 | $93K | Buy |
1,193
+35
| +3% | +$2.73K | 0.05% | 319 |
|
|
2021
Q4 | $104K | Sell |
1,158
-150
| -11% | -$13.5K | 0.05% | 299 |
|
|
2021
Q3 | $121K | Buy |
1,308
+50
| +4% | +$4.63K | 0.08% | 245 |
|
|
2021
Q2 | $98K | Buy |
1,258
+83
| +7% | +$6.47K | 0.06% | 287 |
|
|
2021
Q1 | $88K | Buy |
1,175
+575
| +96% | +$43.1K | 0.06% | 277 |
|
|
2020
Q4 | $102K | Hold |
600
| – | – | 0.08% | 224 |
|
|
2020
Q3 | $84K | Buy |
+600
| New | +$84K | 0.08% | 218 |
|